Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beta Bionics, Inc.(BBNX) | 1,988,287 | 1,988,287 | 0 | $24.34M | $28.95M | 18.75% | +$4.61M |
| Kestra Med Technologies Ltd. SHS | 1,795,893 | 1,645,893 | -150,000 | $44.75M | $27.29M | 17.67% | -$17.46M |
| Upstream Bio, Inc.(UPB) | 2,036,293 | 2,036,293 | 0 | $12.46M | $22.36M | 14.48% | +$9.90M |
| Nuvation Bio Inc.CL A(NUVB) | 13,072,340 | 11,042,728 | -2,029,612 | $23.01M | $21.53M | 13.94% | -$1.47M |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | $28.73M | $20.48M | 13.26% | -$8.25M |
| Replimune Group, Inc.(REPL) | 1,975,203 | 1,975,203 | 0 | $19.26M | $18.35M | 11.88% | -$908.6K |
| Lexeo Therapeutics, Inc.(LXEO) | 1,184,636 | 1,184,636 | 0 | $4.11M | $4.76M | 3.08% | +$651.5K |
| Ikena Oncology | 2,249,123 | 2,249,123 | 0 | $2.88M | $3.01M | 1.95% | +$134.9K |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $1.42M | $2.30M | 1.49% | +$885.9K |
| Alumis Inc. | 653,223 | 653,223 | 0 | $4.01M | $1.96M | 1.27% | -$2.05M |
| enGene Holdings Inc. COM | 526,357 | 526,357 | 0 | $2.36M | $1.92M | 1.24% | -$442.1K |
| Immunic, Inc.(IMUX) | 1,788,160 | 1,788,160 | 0 | $1.95M | $1.25M | 0.81% | -$701.0K |
| enGene Holdings Inc.WARRANT *W EXP 10/31/202 | 321,502 | 321,502 | 0 | $192.9K | $273.0K | 0.18% | +$80.1K |